Tag: VentureMed Group

VentureMed to present new data on DCB treatment for PAD

VentureMed Group has announced new data presentations on the treatment of peripheral arterial disease (PAD) with drug-coated balloon (DCBs) in addition to 12-month AV...

VentureMed announces first patient treated with 75cm-length Flex vessel prep product

VentureMed Group announced today that Ari Kramer (Spartanburg Regional Healthcare System, Spartanburg, USA) has treated the first patient with the Flex vessel prep system...

Flex Vessel Prep system demonstrates favourable six-month results compared to historical...

New data presented at the 2022 Vascular Access for Hemodialysis Symposium (9–11 June, Charleston, USA) have demonstrated favourable outcomes with the Flex Vessel Prep...
Flex Vessel Prep

VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...

VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...